Skip to main content
Caplight Logo









Immobazyme

Immobazyme

Private
Cape TownHealthcare & Life Scienceshttps://www.immobazyme.com/

Last Round

VC Round

Dec 1, 2025

Company Overview

Immobazyme is a biotechnology company that develops and manufactures high-value biological products, including recombinant growth factors, enzymes, and peptides, using a proprietary precision fermentation and enzyme immobilization platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Sustainable Materials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

precision fermentationrecombinant proteinsenzyme immobilizationcellular agriculturebiomanufacturinggrowth factorsanimal-free ingredientscultivated meatlab-grown meatindustrial enzymescontract researchbioprocessingserum replacementbiotechalternative protein

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Immobazyme Comparables

Compare Immobazyme with similar companies based on industry and business-model similarity.

Immobazyme comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sticta Biologicals
85%
Cascade Bio
74%
EnginZyme
71%

Immobazyme Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 1, 2025
VC RoundJun 18, 2024

Key People

Founding team and executive leadership

Ethan Hunter

Co-Founder & COO

Founding Team

Dominic Nicholas

Chief Executive Officer

Executive Team

Immobazyme Investors

Notable investors and investment history

Immobazyme investors
InvestorRounds
Fireball CapitalVC Round
InnovusVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 23, 2026

    Grew 31% QoQ, from 13 to 17 employees.

  • Jan 22, 2026

    Monthly visitors increased 835% MoM to 2.1K.

Immobazyme Filings

Explore SEC and related filing metadata, where available.

Immobazyme filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Immobazyme's valuation, stock price, and market status.

Is Immobazyme a public or private company?

Immobazyme is a private company.

What is the current stock price of Immobazyme?

Immobazyme is a private company with no public stock price. No recent secondary market data is available.

How much is Immobazyme worth (valuation)?

Valuation information for Immobazyme is not publicly available.

Can I buy Immobazyme stock?

Immobazyme shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Immobazyme's last funding round?

Immobazyme's most recent funding round was VC Round on December 1, 2025.

Who are the main investors in Immobazyme?

Key investors in Immobazyme include Innovus.

Will Immobazyme IPO soon?

No public IPO plans have been announced for Immobazyme.

How can I track Immobazyme secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Immobazyme's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCape Town
Employee Range18
Year Founded2019
Last FundingDec 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?